ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106969; 2) Community: the network communities that were significantly associated with the response to NSC 106969; 3) Molecule: the relationships between components within communities and NSC 106969; 4) MDR: the compounds that were significantly associated with the NSC 106969.

NSC Compound Enrichment Correlation
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0220039422291539 -0.023362579
NSC 733467 Null 0.0220039422291539 0.33306262
NSC 737231 Null 0.0220039422291539 0.05173174
NSC 749297 N'-{2-[2-(4-Methoxy-phenyl)-vinyl]quinazolin-4-yl}-N,N-dimethyl-propane-1,3-diamine hydrochloride 0.0220039422291539 0.11168436
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0220039422291539 0.22343774
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0220039422291539 0.32219185
NSC 28365 Null 0.0228506033927954 0.27797514
NSC 140377 Arnebin 1 0.0228506033927956 0.078250317
NSC 274556 Null 0.0228506033927956 0.082466203
NSC 321521 SK&F 39162 0.0228506033927956 0.38775801
Total:95  Current:51    [First] [Prev] [Next] [Last]